Remote Ischemic Preconditioning Induces Myocardial RISK Signaling Pathway in Patients Undergoing Valvular Heart Surgery | NCT01946087 | Trialant
CompletedInterventionalPhase 4Updated Nov 22, 2016
Remote Ischemic Preconditioning Induces Myocardial RISK Signaling Pathway in Patients Undergoing Valvular Heart Surgery
ClinicalTrials.gov ID
NCT01946087
Lead Sponsor
Yonsei UniversityOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Phase 4
Enrollment
79Actual
Last Update Posted
Nov 22, 2016Estimated
Start Date
Jun 2013
Primary Completion Date
Apr 2016Actual
Completion Date
Apr 2016Actual
Brief Summary
The aim of this study is to investigate whether RIPC protects the heart against ischemia reperfusion injury on the concentrically hypertrophied myocardium
Patients With Elective Aortic Valve Replacement
Remote ischemic preconditioning at left upper arm
Control group
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients aged ≥20 years with severe degenerative AS presenting concentric remodeling of the LV, who were scheduled for AVR